PTPRZ1 and malignant glioma: Together with the previous report that identified PTPRZ1 as a stemness classifier gene by single-cell RNA sequencing of primary human glioblastomas26, our results indicate that the R5 RPTP subfamily comprises a novel group of molecular targets for differentiation-inducing therapy for malignant gliomas.